SCHEMBL30712085

SCHEMBL30712085

CCCNCCc1c[nH]c2cccc(O)c12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 12/20 0.74
▸ HTR1A P08908 3/20 0.60
▸ HTR2C P28335 7/20 0.60
▸ HTR2B P41595 6/20 0.59
▸ HTR1D P28221 2/20 0.59
▸ DRD1 P21728 1/20 0.59
▸ HTR1B P28222 1/20 0.59
▸ HTR1E P28566 1/20 0.59
▸ ADORA2A P29274 1/20 0.59
▸ ADORA2B P29275 1/20 0.59
▸ HTR7 P34969 1/20 0.59
▸ DRD3 P35462 1/20 0.59
▸ HTR5A P47898 1/20 0.59
▸ HTR6 P50406 1/20 0.59
▸ SLC6A2 P23975 1/20 0.53
▸ GAA P10253 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30183441 1.00 HTR2A (0.74) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25008718 0.92 HTR2A (0.70) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL29992340 0.90 HTR2A (0.76) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25030287 0.90 HTR2A (0.76) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25008884 0.89 HTR2A (0.67) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25008706 0.89 HTR2A (0.67) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25008704 0.89 HTR2A (0.67) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25008717 0.89 HTR2A (0.67) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL25008687 0.89 HTR2A (0.67) HTR2AHTR1AHTR2CHTR2BHTR1D
SCHEMBL31708127 0.86 HTR2A (0.69) HTR2AHTR1AHTR2CHTR2BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025122474-A1 4-HYDROXY-N-PROPYLTRYPTAMINE CAAMTECH, INC. (US) 2025-06-12 — — WO claimed
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
WO-2025122474-A1 4-HYDROXY-N-PROPYLTRYPTAMINE CAAMTECH, INC. (US) 2025-06-12 — — WO disclosed
WO-2025122474-A1 4-HYDROXY-N-PROPYLTRYPTAMINE CAAMTECH, INC. (US) 2025-06-12 — — WO disclosed
EP-4551212-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024035757-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2024-02-15 — — WO disclosed
Send feedback